About This Study
The purpose of this study is to learn more about a new treatment plan for patients with relapsing multiple sclerosis. We want to see if a new way of giving the medicine ofatumumab every two months is safe and works like the regular monthly dose. Our researchers will check how the medicine affects certain cells and proteins in the blood.
What Activities Are a Part of this Study?
- Informed Consent Review
- Use of Study Treatments or Placebo
- After Study Follow-Up Activities
- Review of Medical History
- Physical Examinations
- Phone Calls and/or Emails
- Study Visits and Consultations
- Surveys/Questionnaires
- Laboratory and Imaging Tests
- Specimen Sample Collection
- Diary/e-Diary Writing or Recordings
Age & Gender
- 18 - 60 years old
- Female
- Male
Language
- This study enrolls English and Spanish speakers
Additional Study Information
- Compensation Offered
- Reimbursement offered
Study Locations
- Greater Charlotte, NC